Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-02-20 @ 3:45 PM
Study NCT ID:
NCT02205632
Status:
COMPLETED
Last Update Posted:
2018-04-05
First Post:
2014-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.
Sponsor:
Poitiers University Hospital
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lutein ans zeaxanthin, carotenoids provided by dietary intake are mainly located in the macular area.
Its absorption peak at 460 nm may reduce photic damages. The macular pigment density can be evaluated by its optical density.
Reduced macular pigment level is a significant risk factor for age-macular degeneration. The nutritional intake can minimise the risk of age-macular degeneration.
Its absorption peak at 460 nm may reduce photic damages. The macular pigment density can be evaluated by its optical density.
Reduced macular pigment level is a significant risk factor for age-macular degeneration. The nutritional intake can minimise the risk of age-macular degeneration.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: